124 related articles for article (PubMed ID: 26351803)
21. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer.
Tokunaga E; Nakashima Y; Yamashita N; Hisamatsu Y; Okada S; Akiyoshi S; Aishima S; Kitao H; Morita M; Maehara Y
Breast Cancer; 2014 May; 21(3):341-9. PubMed ID: 22903204
[TBL] [Abstract][Full Text] [Related]
22. SND1 promotes the proliferation of osteosarcoma cells by upregulating COX‑2/PGE2 expression via activation of NF‑κB.
Zhou M; Wang A; Yin B; Wu D; Han S; Zhang W; Liu J; Sun K
Oncol Rep; 2019 Jan; 41(1):579-589. PubMed ID: 30365124
[TBL] [Abstract][Full Text] [Related]
23. Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression.
Tian W; Hao S; Gao B; Jiang Y; Zhang X; Zhang S; Guo L; Zhao J; Zhang G; Chen Y; Li Z; Luo D
Drug Des Devel Ther; 2018; 12():3563-3571. PubMed ID: 30464390
[TBL] [Abstract][Full Text] [Related]
24. Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and SND1 Interaction.
Chen H; Zhan M; Liu J; Liu Z; Shen M; Yang F; Kang Y; Yin F; Li Z
J Med Chem; 2022 Sep; 65(18):12188-12199. PubMed ID: 36044768
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer.
Liang Y; Hu J; Li J; Liu Y; Yu J; Zhuang X; Mu L; Kong X; Hong D; Yang Q; Hu G
Cancer Res; 2015 Sep; 75(17):3672-80. PubMed ID: 26141861
[TBL] [Abstract][Full Text] [Related]
26. Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival.
Zhou J; Li J; Wang Z; Yin C; Zhang W
Asia Pac J Clin Oncol; 2012 Sep; 8(3):e42-8. PubMed ID: 22898150
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.
Meng X; Zhu D; Yang S; Wang X; Xiong Z; Zhang Y; Brachova P; Leslie KK
J Biol Chem; 2012 Feb; 287(7):4485-91. PubMed ID: 22199357
[TBL] [Abstract][Full Text] [Related]
28. MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancer.
Nikpour M; Emadi-Baygi M; Fischer U; Niegisch G; Schulz WA; Nikpour P
Urol Oncol; 2014 Jul; 32(5):670-7. PubMed ID: 24495449
[TBL] [Abstract][Full Text] [Related]
29. Drug resistance mediated by AEG-1/MTDH/LYRIC.
Meng X; Thiel KW; Leslie KK
Adv Cancer Res; 2013; 120():135-57. PubMed ID: 23889990
[TBL] [Abstract][Full Text] [Related]
30. NF-κB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene.
Armengol S; Arretxe E; Rodríguez L; Ochoa B; Chico Y; Martínez MJ
Biochimie; 2013 Apr; 95(4):735-42. PubMed ID: 23160072
[TBL] [Abstract][Full Text] [Related]
31. Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin.
Wei YB; Guo Q; Gao YL; Yan B; Wang Z; Yang JR; Liu W
Mol Med Rep; 2015 Jul; 12(1):226-32. PubMed ID: 25684730
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
33. Exploring binding modes of the selected inhibitors to SND1 by all-atom molecular dynamics simulations.
Pang P; Liu S; Hao X; Tian Y; Gong S; Miao D; Zhang Y
J Biomol Struct Dyn; 2023 Jun; ():1-15. PubMed ID: 37345536
[TBL] [Abstract][Full Text] [Related]
34. Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer.
Haug S; Schnerch D; Halbach S; Mastroianni J; Dumit VI; Follo M; Hasenburg A; Köhler M; Dierbach H; Herzog S; Proske A; Werner M; Dengjel J; Brummer T; Laßmann S; Wäsch R; Zeiser R
Int J Cancer; 2015 May; 136(10):2328-40. PubMed ID: 25346496
[TBL] [Abstract][Full Text] [Related]
35. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
Li W; Zhai L; Zhao C; Lv S
Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
[TBL] [Abstract][Full Text] [Related]
36. N-Glycosylation on Asn50 of SND1 Is Required for Glioma U87 Cell Proliferation and Metastasis.
Zhou Y; Li Q; Zheng J; Lin N
J Immunol Res; 2022; 2022():5239006. PubMed ID: 36213325
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.
Kuruma H; Kamata Y; Takahashi H; Igarashi K; Kimura T; Miki K; Miki J; Sasaki H; Hayashi N; Egawa S
Am J Pathol; 2009 Jun; 174(6):2044-50. PubMed ID: 19435788
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.
Liu Y; Su Z; Li G; Yu C; Ren S; Huang D; Fan S; Tian Y; Zhang X; Qiu Y
Int J Cancer; 2013 Aug; 133(3):671-9. PubMed ID: 23364922
[TBL] [Abstract][Full Text] [Related]
40. Metadherin is required for the proliferation, migration, and invasion of esophageal squamous cell carcinoma and its meta-analysis.
Yang C; Zheng S; Liu Q; Liu T; Lu M; Dai F; Gao X; Sheyhidin I; Lu X
Transl Res; 2015 Dec; 166(6):614-626.e2. PubMed ID: 26051629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
